Sentra Biosains Dinamika


Noninvasive prenatal testing (NIPT)

Panorama is a blood-based genetic, prenatal screening test of the pregnant person that screens for common chromosomal conditions that affect a baby’s health. Panorama uses SNP*-based technology to deliver highly accurate results and unique insights for both singleton and twin pregnancies

Panorama can be performed as early as nine weeks gestation. Most results will be returned to your doctor within 5-7 calendar days.

Panorama is a screening test, which means that this test does not make a final diagnosis. A high risk result means that your pregnancy has a higher chance of having a specific genetic condition. However, you cannot know for sure if your baby has that condition based upon the screening result alone. All medical decisions should be made after discussion with your healthcare provider regarding diagnostic testing during the pregnancy, like chorionic villus sampling (CVS) or amniocentesis, or testing the baby after birth.
*SNP, single nucleotide polymorphism

The only SNP-based NIPT delivers more insights with high accuracy1,2

Panorama is:

  • validated in the largest prospective NIPT study ever
  • the only NIPT that distinguishes the pregnant person’s DNA from baby’s DNA
  • the approach that creates unique, clinically validated capabilities

Panorama evaluates SNPs— the 1% of our DNA that makes us different from one another

Related Products